top of page

CONTINUUS Pharmaceuticals Awarded $4.4 M Contract with US FDA

Wednesday, November 16th, 2016 - General News

CONTINUUS Pharmaceuticals, Inc. was recently awarded a $4.4 M contract by the US Food and Drug Administration (US FDA).  The purpose of this collaborative work, entitled “Advancement of Integrated Continuous Manufacturing (ICM) Unit Operations,” is to develop a science and risk-approach on how drug quality can be monitored and improved through integrated continuous manufacturing (ICM).  This work may inform future regulatory guidelines that the pharmaceutical industry can leverage when developing such processes.  To achieve this goal, the CONTINUUS team will  develop a fully automated, end-to-end, integrated continuous pilot plant that will be used to test relevant regulatory principles, including real-time release and traceability. The time frame for this project is three years. Read more about it here

Recent Posts

See All

CONTINUUS ON SHOW AT CHPI 2022

Monday, September 26th, 2022 - General News CPHI 2022 is just around the corner and CONTINUUS is pleased to be part of it! From November...

Comments


Contact Us

25 Olympia Ave, Woburn,

MA 01801, USA

  • LinkedIn
  • Youtube
  • Twitter
bottom of page